Search

Your search keyword '"Kurian, Benji"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Kurian, Benji" Remove constraint Author: "Kurian, Benji"
214 results on '"Kurian, Benji"'

Search Results

2. Discovery and replication of cerebral blood flow differences in major depressive disorder

3. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals

5. Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

6. Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control

8. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study

9. Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC study

10. Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial

12. Neuroticism and Individual Differences in Neural Function in Unmedicated Major Depression: Findings From the EMBARC Study

13. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

14. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design

16. Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial

18. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report

20. Test–retest reliability of freesurfer measurements within and between sites: Effects of visual approval process

24. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression

25. Predictive Patterns of Antidepressant Response from Pre-Treatment Reward Processing using Functional MRI and Deep Learning: Key Results from the EMBARC Randomized Clinical Trial

28. Evidence Of Differential Changes In Cortical Thickness And Volume Between Ssri And Placebo Treated Patients With Major Depressive Disorder

29. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals

30. Discovery and replication of cerebral blood flow differences in major depressive disorder

31. Cerebral Blood Perfusion Moderates Treatment Response to Sertraline in Major Depressive Disorder

32. O14. Cerebral Blood Perfusion Predicts Response to Antidepressant Treatment in Major Depressive Disorder

33. 133. Baseline Functional Connectivity and Cerebral Perfusion Markers of Response to Sertraline Vs. Placebo: A Data-Driven Multi-Modal Neuroimaging Study

34. Development and evaluation of a multimodal marker of major depressive disorder

35. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study

36. S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive Disorder

37. S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive Disorder

38. 176. Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder

39. S107. Identifying Characteristics of Placebo Responders in Major Depression From the EMBARC Study

41. 939. Identifying Clinically Relevant Electroencephalography Coherence Patterns in Major Depressive Disorder: Results from the EMBARC Study

42. Comprehensive Versus Usual Community Care For First Episode Psychosis: Two-Year Outcomes From The NIMH RAISE Early Treatment Program

43. Demonstrating test‐retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment response

44. Test-retest Reliability Of Freesurfer Measurements Within And Between Sites: Effects Of Visual Approval Process: Test-retest Reliability Of Freesurfer Measurements

45. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

46. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

47. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

48. A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER

49. Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study

50. Early Adverse Events and Attrition in SSRI Treatment: A Suicide Assessment Methodology Study (SAMS) Report

Catalog

Books, media, physical & digital resources